PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
173.56%
Revenue growth above 1.5x 5715.T's 15.90%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
81.63%
Gross profit growth above 1.5x 5715.T's 33.75%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
253.58%
EBIT growth above 1.5x 5715.T's 64.46%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
299.78%
Operating income growth above 1.5x 5715.T's 110.38%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
419.93%
Positive net income growth while 5715.T is negative. John Neff might see a big relative performance advantage.
419.48%
Positive EPS growth while 5715.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
419.48%
Positive diluted EPS growth while 5715.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-84.40%
Negative 10Y revenue/share CAGR while 5715.T stands at 62.79%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
14.43%
Positive 5Y CAGR while 5715.T is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
67.84%
Positive 3Y CAGR while 5715.T is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
105.75%
Net income/share CAGR at 75-90% of 5715.T's 121.33%. Bill Ackman would press for strategic moves to boost long-term earnings.
-28.00%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
253.81%
Positive short-term CAGR while 5715.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
-64.77%
Negative equity/share CAGR over 10 years while 5715.T stands at 74.23%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
138.62%
5Y equity/share CAGR above 1.5x 5715.T's 68.59%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
24.93%
3Y equity/share CAGR at 50-75% of 5715.T's 41.88%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
128.89%
AR growth well above 5715.T's 13.19%. Michael Burry fears inflated revenue or higher default risk in the near future.
-58.42%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.52%
Asset growth above 1.5x 5715.T's 0.13%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
8.07%
Similar to 5715.T's 8.87%. Walter Schloss finds parallel capital usage or profit distribution strategies.
-4.53%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-18.56%
Our R&D shrinks while 5715.T invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
142.69%
We expand SG&A while 5715.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.